AIP
EWTX icon

Ameritas Investment Partners’s Edgewise Therapeutics EWTX Stock Holding History

Ameritas Investment Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
6,491
+853
+15% +$29.4K 0.01% 1228
2026
Q1 		$178K Hold
5,638
– – 0.01% 1341
2025
Q4 		$140K Hold
5,638
– – ﹤0.01% 1495
2025
Q3 		$91.4K Sell
5,638
-1,956
-26% -$27.7K ﹤0.01% 1743
2025
Q2 		$99.6K Hold
7,594
– – ﹤0.01% 1761
2025
Q1 		$167K Hold
7,594
– – 0.01% 1382
2024
Q4 		$203K Buy
7,594
+482
+7% +$15.3K 0.01% 1315
2024
Q3 		$190K Hold
7,112
– – 0.01% 1360
2024
Q2 		$128K Buy
7,112
+1,361
+24% +$23.7K ﹤0.01% 1574
2024
Q1 		$105K Buy
5,751
+1,561
+37% +$24.8K ﹤0.01% 1706
2023
Q4 		$45.8K Hold
4,190
– – ﹤0.01% 2223
2023
Q3 		$24K Buy
4,190
+1,200
+40% +$8.16K ﹤0.01% 2453
2023
Q2 		$23.2K Hold
2,990
– – ﹤0.01% 2490
2023
Q1 		$19.9K Hold
2,990
– – ﹤0.01% 2470
2022
Q4 		$31.7K Hold
2,990
– – ﹤0.01% 2335
2022
Q3 		$29K Hold
2,990
– – ﹤0.01% 2322
2022
Q2 		$23K Hold
2,990
– – ﹤0.01% 2484
2022
Q1 		$29K Hold
2,990
– – ﹤0.01% 2382
2021
Q4 		$46K Buy
2,990
+2,023
+209% +$36.4K ﹤0.01% 2177
2021
Q3 		$16K Hold
967
– – ﹤0.01% 2801
2021
Q2 		$21K Buy
+967
New +$26.4K ﹤0.01% 2704

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameritas Investment Partners's EWTX Position: Q2 2026 in Review

Ameritas Investment Partners increased its Edgewise Therapeutics (EWTX) stake by 15% in Q2 2026, buying an estimated $29.4K and bringing the position to 6,491 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #1228.

Ameritas Investment Partners first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Ameritas Investment Partners held 6,491 shares of Edgewise Therapeutics worth $264K as of Q2 2026.
  • Ameritas Investment Partners bought 853 Edgewise Therapeutics shares in Q2 2026, an estimated $29.4K.
  • Edgewise Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1228 holding.
  • Ameritas Investment Partners first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.